Larimar Therapeutics
LRMR
LRMR
69 hedge funds and large institutions have $180M invested in Larimar Therapeutics in 2023 Q4 according to their latest regulatory filings, with 8 funds opening new positions, 23 increasing their positions, 25 reducing their positions, and 3 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
more first-time investments, than exits
New positions opened: | Existing positions closed:
more capital invested
Capital invested by funds: $ → $
more funds holding
Funds holding: →
0.46% more ownership
Funds ownership: 89.52% → 89.99% (+0.46%)
0% more funds holding in top 10
Funds holding in top 10: 2 → 2 (0)
8% less repeat investments, than reductions
Existing positions increased: 23 | Existing positions reduced: 25
Holders
69
Holding in Top 10
2
Calls
$378K
Puts
$83K
Top Buyers
| 1 | +$15.5M | |
| 2 | +$1.24M | |
| 3 | +$819K | |
| 4 |
BlackRock
New York
|
+$724K |
| 5 |
Adage Capital Partners
Boston,
Massachusetts
|
+$455K |
Top Sellers
| 1 | -$1.35M | |
| 2 | -$1.02M | |
| 3 | -$675K | |
| 4 |
Verition Fund Management
Greenwich,
Connecticut
|
-$407K |
| 5 |
IC
Ikarian Capital
Dallas,
Texas
|
-$364K |